a study on Venous Thromboembolism
To assess the safety and extrapolated efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
A Randomized, Open-label, Active Controlled, Safety And Extrapolated Efficacy Study In Pediatric Subjects Requiring Anticoagulation For The Treatment Of A Venous Thromboembolic Event
Venous Thromboembolism VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis Apixaban
Open to people ages up to 17 years
This step makes sure spammers don’t flood our inbox
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT02464969.
© 2017 The Regents of the University of California